 BAUDETTE, Minn.--BUSINESS WIRE--ANI Pharmaceuticals, Inc. ANI or the Company NASDAQ: ANIP today announced business highlights and financial results for the three and 12 months ended December 31, 2020. Corporate Strategy The Companys strategy for sustainable future growth is based on four key pillars: Build a successful Cortrophin franchise; Strengthen the Generics business by enhancing development capabilities and increased focus on niche opportunities. The acquisition of Novitium Ph 